FDA Inspection 1059419 — King Bio Inc.
The FDA completed an inspection of King Bio Inc. on July 20, 2018 in Asheville, NC. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- July 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Asheville, NC (United States)